QuantumCell ApS

Private limited companyCVR 45663205København KActive

QuantumCell ApS is a private limited company, based in København K, active in manufacture of pharmaceutical preparations, founded in 2025. The company is new and has been registered for 1 years. The latest net result (2025) was a loss of DKK 8.2m.

Follow
PDF reportCompare

Key figures · financial year 2025

Gross profit−DKK 8.2m
Net profit−DKK 8.2m
EquityDKK 27.6m
Employees4latest month from CVR

What has changed

calculated from recorded figures and dates

Management and owners, last 24 months

  • New in management: Peter Finsel Bisgaard (chair of the board, 07/06/2025), Søren Møller (board member, 15/10/2025) and Christian Ellebæk Elling (board member, 15/10/2025) (+11).
  • Stepped down: Peter Høngård Andersen (board member, 15/10/2025), Kasper Lage Hansen (director, 30/11/2025) and Kasper Lage Hansen (board member, 18/09/2026) (+2).
  • New owners registered: Lundbeckfond Invest A/S (21/09/2026), Novo Holdings A/S (21/09/2026) and Danmarks Eksport- og Investeringsfond (21/09/2026) (+21).
  • No longer registered as owner: Peter Finsel Bisgaard (15/10/2025), Hongaard Holding ApS (15/10/2025) and BHNS Holding ApS (14/10/2025) (+14).

Registrations, last 24 months

  • 21/09/2026: Share capital changed from 1,227,310 DKK to 1,518,644 DKK
  • 01/09/2026: Moved to Farvergade 10, 4, 1463 København K
  • 10/07/2026: Share capital changed from 570,900 DKK to 1,227,310 DKK
  • 08/06/2026: Share capital changed from 638,100 DKK to 570,900 DKK
  • 26/01/2026: Moved to Nordre Fasanvej 215, 2000 Frederiksberg
  • 15/10/2025: Share capital changed from 30,000 DKK to 638,100 DKK

Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.

Financial statements

Financial years 2025–2025 · amounts in DKK thousand
Financial figures for QuantumCell ApS
2025Change
Revenuenot stated–
Gross profit−8,169–
Operating profit (EBIT)−8,781–
Profit before tax−9,419–
Net profit−8,192–
Total assets31,425–
Equity27,589–
Liabilities3,835–
Cash and cash equivalents29,244–
Average number of employees1–

Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2025: smaller companies may omit it, and we do not derive it from other figures.

Download the figures as CSV · free with an account, amounts in whole DKK

Annual reports

1 financial years
Annual reports for QuantumCell ApS
Financial yearPeriodPublishedFigures forDocuments
202507/06/2025 – 31/12/202509/06/2026The companyPDF not statedXBRL

The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.

Employees

monthly figures from CVR
0123412/2501/2602/2603/2604/2605/2606/2607/26
Employees

Position in the industry

59 companies in the database

Comparison with the other companies in manufacture of pharmaceutical preparations based on the latest financial year.

Gross profit−DKK 8.2mNo. 49 of 57
Better than 14% of the companies in the industry
EquityDKK 27.6mNo. 22 of 59
Better than 64% of the companies in the industry
Number of employees4No. 46 of 59
Better than 22% of the companies in the industry

Industry median: gross profit DKK 2.8m, net profit −DKK 2.2m, equity DKK 5.2m, 10 employees.

DKK 266kDKK 8.3mDKK 258mDKK 8bnDKK 79.6bn
Distribution of gross profit for 34 companies in the industry (latest financial year, logarithmic scale). Amber bar: where this company sits.

Compared with similar companies

size, age and company form
Rank among similar companies
GroupGross profitEquity
Companies with fewer than 20 employees69,967 companies in the comparison
No. 69,613of 69,742
Better than 0%
No. 4,716of 69,964
Better than 93%
Same industry and fewer than 20 employees37 companies in the comparison
No. 31of 36
Better than 14%
No. 7of 37
Better than 83%
Companies that are founded within the last five years16,662 companies in the comparison
No. 16,572of 16,614
Better than 0%
No. 470of 16,661
Better than 97%
All companies of type ApS66,508 companies in the comparison
No. 66,263of 66,379
Better than 0%
No. 3,357of 66,505
Better than 95%

The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.

Compare with the industry

Manufacture of pharmaceutical preparations
Gross profit
  1. QuantumCell ApS−DKK 8.2m
  2. Novo Nordisk A/SDKK 250.3bn
  3. H. Lundbeck A/SDKK 20.4bn
Net profit
  1. QuantumCell ApS−DKK 8.2m
  2. Novo Nordisk A/SDKK 102.4bn
  3. H. Lundbeck A/SDKK 3.2bn
Equity
  1. QuantumCell ApSDKK 27.6m
  2. Novo Nordisk A/SDKK 194bn
  3. H. Lundbeck A/SDKK 24.9bn
Employees
  1. QuantumCell ApS4
  2. Novo Nordisk A/S27,279
  3. H. Lundbeck A/S2,261

Latest financial year per company. Choose up to three companies from the largest in the industry.

Owners and group

from the Public Ownership Register
Owners
QuantumCell ApS

Management

9 active registrations

Executive management

Executive management at QuantumCell ApS
NameRoleAppointed
Mads Kristian DalsgaardDirector01/08/2026
Saraswati Rudraji Kenkare-MitraCEO01/08/2026

Board of directors

Board of directors at QuantumCell ApS
NameRoleAppointed
Peter Finsel BisgaardChair of the board07/06/2025
Søren MøllerBoard member15/10/2025
Christian Ellebæk EllingBoard member15/10/2025
Marco BoorsmaBoard member15/10/2025
Manish KothariBoard member15/10/2025
Goran Mikael DolstenBoard member06/08/2026
Saraswati Rudraji Kenkare-MitraBoard member18/09/2026
Founders
Peter Finsel Bisgaard, Hongaard Holding ApS, BHNS Holding ApS
Former management (5)
Former management at QuantumCell ApS
NameRoleAppointedResigned
Peter Høngård AndersenBoard member07/06/202515/10/2025
Kasper Lage HansenDirector07/06/202530/11/2025
Kasper Lage HansenBoard member07/06/202518/09/2026
Anta GkelouBoard member15/10/202508/06/2026
Mads Kristian DalsgaardCEO01/12/202531/07/2026

Signing rule: Selskabet tegnes af to medlemmer af bestyrelsen i forening, af en direktør i forening med bestyrelsesformanden, eller af den samlede bestyrelse.

Address and production units

1 active production units

Farvergade 10
1463 København K

København Municipality · Postcode 1463

Production units
Production unitAddressEmployeesP number
QuantumCell ApSFarvergade 10, 4, 1463 København K41031399137

Purpose

Virksomhedens formål er forskning, udvikling og kommercialisering af lægemidler og anden beslægtet virksomhed.

The purpose is quoted from the register in Danish.

Changes year by year

69 registered events
202641 changescapital 3 · ownership 28 · management 7 · address 2 · accounts 1
  • Share capital changed from 1,227,310 DKK to 1,518,644 DKK
  • LUNDBECKFOND INVEST A/S registered as owner (15%)
  • ForDD Ventures VII B.V. registered as owner (5%)
  • Stichting Juridisch eigendom ForCal I registered as owner (5%)
  • First Spark Venture Fund, L.P. registered as owner (15%)
  • Forbion Ventures Fund VII registered as owner (10%)
  • Danmarks Eksport- og Investeringsfond registered as owner (10%)
  • Novo Holdings A/S registered as owner (15%)
  • Novo Holdings A/S is no longer registered as owner
  • LUNDBECKFOND INVEST A/S is no longer registered as owner
  • Danmarks Eksport- og Investeringsfond is no longer registered as owner
  • Forbion Ventures Fund VII is no longer registered as owner
  • First Spark Venture Fund, L.P. is no longer registered as owner
  • Stichting Juridisch eigendom ForCal I is no longer registered as owner
  • ForDD Ventures VII B.V. is no longer registered as owner
  • Saraswati Rudraji Kenkare-Mitra appointed board member
  • Kasper Lage Hansen stepped down as board member
  • Moved to Farvergade 10, 4, 1463 København K
  • Goran Mikael Dolsten appointed board member
  • Saraswati Rudraji Kenkare-Mitra appointed ceo
  • Mads Kristian Dalsgaard appointed director
  • Mads Kristian Dalsgaard stepped down as ceo
  • Share capital changed from 570,900 DKK to 1,227,310 DKK
  • Novo Holdings A/S registered as owner (15%)
  • LUNDBECKFOND INVEST A/S registered as owner (15%)
  • Danmarks Eksport- og Investeringsfond registered as owner (5%)
  • Forbion Ventures Fund VII registered as owner (5%)
  • First Spark Venture Fund, L.P. registered as owner (15%)
  • Stichting Juridisch eigendom ForCal I registered as owner (5%)
  • BHNS Holding ApS is no longer registered as owner
  • Trophic Aps is no longer registered as owner
  • LUNDBECKFOND INVEST A/S is no longer registered as owner
  • Novo Holdings A/S is no longer registered as owner
  • First Spark Venture Fund, L.P. is no longer registered as owner
  • Forbion Ventures Fund VII is no longer registered as owner
  • Annual report for 2025 published
  • Share capital changed from 638,100 DKK to 570,900 DKK
  • Anta Gkelou stepped down as board member
  • Sofinnova Capital XI SCSp SICAV-RAIF is no longer registered as owner
  • ForDD Ventures VII B.V. registered as owner (5%)
  • Moved to Nordre Fasanvej 215, 2000 Frederiksberg
202528 changesmanagement 12 · name 1 · capital 1 · ownership 13 · founded 1
  • Mads Kristian Dalsgaard appointed ceo
  • Kasper Lage Hansen stepped down as director
  • Name changed from qCell ApS to QuantumCell ApS
  • Share capital changed from 30,000 DKK to 638,100 DKK
  • Christian Ellebæk Elling appointed board member
  • Anta Gkelou appointed board member
  • Søren Møller appointed board member
  • Marco Boorsma appointed board member
  • Manish Kothari appointed board member
  • Peter Høngård Andersen stepped down as board member
  • LUNDBECKFOND INVEST A/S registered as owner (10%)
  • Novo Holdings A/S registered as owner (20%)
  • First Spark Venture Fund, L.P. registered as owner (15%)
  • Sofinnova Capital XI SCSp SICAV-RAIF registered as owner (10%)
  • BHNS Holding ApS registered as owner (5%)
  • Forbion Ventures Fund VII registered as owner (15%)
  • Trophic Aps registered as owner (5%)
  • Hongaard Holding ApS is no longer registered as owner
  • Peter Finsel Bisgaard is no longer registered as owner
  • BHNS Holding ApS is no longer registered as owner
  • Registered as qCell ApS
  • Peter Høngård Andersen appointed board member
  • Peter Finsel Bisgaard appointed chair of the board
  • Kasper Lage Hansen appointed board member
  • Kasper Lage Hansen appointed director
  • Hongaard Holding ApS registered as owner (33.33%)
  • BHNS Holding ApS registered as owner (33.33%)
  • Peter Finsel Bisgaard registered as owner (33.33%)

Related companies

Same industry in København

See all →

Same people in management

Largest in the industry

See all →

Source and updates

The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026. The company is protected against advertising; contact details are not shown, and the data must not be used for marketing.

View in CVRReport a correction